Obstetric outcome in women with hepatitis C virus infection and thyroid dysfunction

References

• Erksen NL. Perinatal consequences of Hepatitis C. Clin Obstet Gynecol. 1999; 42: 121–33
   PubMed Web of Science ®Google Scholar
• Uehara S, Abe Y, Saito T, Yoshida Y, Wagatsuma S, Okamura K, et al. The incidence of vertical transmission of hepatitis C virus. Tohoku J Exp Med. 1993; 171: 195–202
   PubMed Web of Science ®Google Scholar
• Reinus JF, Leikin EL, Alter HJ, Cheung L, Shindo M, Jett B, et al. Failure to detect vertical transmission of heptatitis C virus. Ann Intern Med. 1992; 117: 881–6
   PubMed Web of Science ®Google Scholar
• Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C (HCV) infection and rate of vertical transmission in a cohort of 15,250 pregnant women. Hepatology. 2000; 31: 751–5
   PubMed Web of Science ®Google Scholar
• Kumar A, Sharma KA, Gupta RK, Kar P, Murthy NS. Hepatitis C virus infection during pregnancy in North India. Int J Gynaecol Obstet. 2005; 88: 55–6
   PubMed Web of Science ®Google Scholar
• Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, et al. Thyroid disorders in chronic hepatitis C. Am J Med. 2004; 117: 10–3
   PubMed Web of Science ®Google Scholar
• Broussolle C, Steineur MP, Bailly F, Zoulim F, Trepo C. Hepatitis C virus infection and thyroid diseases. Rev Med Interne. 1999; 20: 766–73
   PubMed Web of Science ®Google Scholar
• Muratori L, Bogdanos DP, Muratori P, Lenzi M, Granito A, Ma Y, et al. Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol. 2005; 3: 595–603
   PubMed Web of Science ®Google Scholar
• Kumar A, Gupta N, Nath T, Sharma JB, Sharma S. Thyroid function in pregnancy. Ind J Med Sci. 2003; 57: 252–8
   PubMedGoogle Scholar
• FG Cunningham, Leveno, KJ, Bloom, SL, Hauth, JC, Gilstrap, L, Wenstrom, KD. Thyroid and other endocrine disorder. In: Williams obstetrics22nd edn. New York: McGraw Hill, 2005. pp. 1189–208.
   Google Scholar
• Floreani D, Paternoster F, Zappalà R, Cusinato R, Bombi G, Grella P, et al. Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol. 1996; 103: 325–9
   PubMedGoogle Scholar
• Paternoster F, Fabris G, Palù C, Santarossa C, Bracciante R, Snijders D, et al. Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection. Acta Obstet Gynecol Scand. 2002; 81: 99–103
   PubMed Web of Science ®Google Scholar
• Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado Thyroid Disease Prevalence Study. Arch Intern Med. 2000; 160: 526–34
   PubMed Web of Science ®Google Scholar
• Fernandez-Soto L, Gonzalez A, Escobar-Jimenez A, Vazquez R, Ocete E, Olea N, et al. Increased risk of autoimmune thyroid disease in hepatitis C versus hepatitis B before, during and after discontinuing interferon therapy. Arch Intern Med. 1998; 158: 1445–8
   PubMed Web of Science ®Google Scholar
• Huang MJ, Wu SS, Liaw YF. Thyroid abnormalities in patients with chronic viral hepatitis. Hepatology. 1994; 20: 1651–2
   PubMed Web of Science ®Google Scholar
• Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Persani L, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol. 1995; 132: 587–93
   PubMed Web of Science ®Google Scholar
• Quaranta JF, Tran A, Regnier D, Letestu R, Beusnel C, Fuzibet JG, et al. High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies. J Hepatol. 1993; 18: 136–8
   PubMed Web of Science ®Google Scholar
• Woeber KA. Subclinical thyroid dysfunction. Arch Intern Med. 1997; 157: 1065–8
   PubMedGoogle Scholar
• Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004; 291: 228–38
   PubMed Web of Science ®Google Scholar
• Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003; 13: 3–126
   PubMed Web of Science ®Google Scholar
• Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005; 105: 239–45
   PubMed Web of Science ®Google Scholar
• Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999; 341: 549–55
   PubMed Web of Science ®Google Scholar
• Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol. 1999; 50: 149–55
   PubMed Web of Science ®Google Scholar
• Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, Liaw YF. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol. 1999; 50: 503–9
   PubMed Web of Science ®Google Scholar
• Monzani F, Caraccio N, Del Guerra P, Casolaro A, Ferrannini E. Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy. Clin Endocrinol. 1999; 51: 237–42
   PubMed Web of Science ®Google Scholar